Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

IO Biotech: Christine Richter SVP, Commercial & Program Lead (2023-06-01)
IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced today that biopharma executive Christine Richter joined the company as SVP, Commercial and P...
VarmX: €30m Series B2 Led by Sound Bioventures & EIC Fund (2023-05-30)
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces it has successfully raised an additional €30 million in a Series B2 financing round. The round was led by Sound Bioventures whilst ...
ElevateBio: $401m Series D Round Led by AyurMaya Capital (2023-05-24)
> Proceeds enable expansion and scale of ElevateBio’s cell and gene technology platforms, end-to-end capabilities, and therapeutic pipeline to serve an increasing number of biopharmaceutical partners and drive revenue growth > ElevateBio has added more than 15 n...
CEBR Appoints New President and Vice-President (2023-05-17)
> CEBR celebrates its Board elections within the frame of its Annual Meeting 2023, taking place in Stuttgart on the 16th and 17th of May. > Forty representatives from the members’ organizations meet in Stuttgart to attend this key event for cluster managers. ...
Biocartis & HiloProbe Partner on Colorectal Cancer Test (2023-05-09)
Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), and HiloProbe, a Umeå (Sweden) based biotechnology company focused on personalizing colorectal cancer diagnostics, today announce that they en...
Neogap & Cellerys Partner for Phase 2 MS Cell Therapy Study (2023-05-04)
NEOGAP Therapeutics, a privately held biopharmaceutical company focusing on immuno-oncology based at the Centre for Molecular Medicine at Karolinska Institutet, Stockholm, Sweden, and Cellerys, a Zurich-based company researching an innovative therapy to fight multi...
Finnish EniferBio Raises €11m Series A Led by Aqua-Spark (2023-04-19)
The successful A-round was led by Aqua-Spark and joined by Tesi, Valio, Voima Ventures, and Nordic Foodtech VC. With the investment, eniferBio will begin to scale the production of its PEKILO® mycoprotein powder, which contains very high levels of protein, healthy ...
Argenx & Genmab Partner for Antibody Therapies (2023-04-17)
> Genmab and argenx have entered into a multiyear collaboration bringing together capabilities to jointly discover, develop and commercialize antibody therapies > Discovery programs against two differentiated targets are underway argenx SE (Euronext & Nasda...
Complement Therapeutics Secures €72m Series A (2023-04-17)
> Round led by Gimv, a Belgian based private equity and venture capital firm > Round comes just 1 year after raising €5 million seed funding in February 2022 > Company aims to transform the treatment of complement mediated conditions Complement Therapeut...
Alentis’ $105m Series C Led by Jeito with Novo & RA Capital (2023-04-13)
Proceeds will fund: > Clinical programs ALE.F02 and ALE.C04 – two first-in-class anti-Claudin-1 (CLDN1) antibodies for organ fibrosis and CLDN1 positive tumors > The platform to engineer CLDN1 antibody drug conjugates (ADC) and bispecific antibodies Alen...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

» Start here with the latest News!

Picture Campus Berlin-Buch at BIO2023 Location of Future Innovation 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)